Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 241

Similar articles for PubMed (Select 15701106)

1.

Duration of untreated psychosis and outcome in first-episode psychosis. Perspective from a developing country.

Oosthuizen P, Emsley RA, Keyter N, Niehaus DJ, Koen L.

Acta Psychiatr Scand. 2005 Mar;111(3):214-9.

PMID:
15701106
2.

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.

J Clin Psychiatry. 2006 Oct;67(10):1511-21.

PMID:
17107241
3.

Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review.

Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T.

Arch Gen Psychiatry. 2005 Sep;62(9):975-83.

PMID:
16143729
4.

Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort.

Schimmelmann BG, Huber CG, Lambert M, Cotton S, McGorry PD, Conus P.

J Psychiatr Res. 2008 Oct;42(12):982-90. doi: 10.1016/j.jpsychires.2007.12.001. Epub 2008 Jan 15.

PMID:
18199456
5.

Does treatment delay in first-episode psychosis really matter?

Harrigan SM, McGorry PD, Krstev H.

Psychol Med. 2003 Jan;33(1):97-110.

PMID:
12537041
6.

A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.

Perez-Iglesias R, Crespo-Facorro B, Amado JA, Garcia-Unzueta MT, Ramirez-Bonilla ML, Gonzalez-Blanch C, Martinez-Garcia O, Vazquez-Barquero JL.

J Clin Psychiatry. 2007 Nov;68(11):1733-40.

PMID:
18052567
7.

Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients.

Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, van Os J.

Schizophr Res. 2001 Apr 30;49(3):231-41.

PMID:
11356584
8.

Is violence at presentation by patients with first-episode psychosis associated with duration of untreated psychosis?

Foley SR, Browne S, Clarke M, Kinsella A, Larkin C, O'Callaghan E.

Soc Psychiatry Psychiatr Epidemiol. 2007 Aug;42(8):606-10. Epub 2007 Jun 27.

PMID:
17598060
9.

Does duration of untreated psychosis bias study samples of first-episode psychosis?

Friis S, Melle I, Larsen TK, Haahr U, Johannessen JO, Simonsen E, Opjordsmoen S, Vaglum P, McGlashan TH.

Acta Psychiatr Scand. 2004 Oct;110(4):286-91.

PMID:
15352930
10.

Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach.

Carbone S, Harrigan S, McGorry PD, Curry C, Elkins K.

Acta Psychiatr Scand. 1999 Aug;100(2):96-104.

PMID:
10480195
11.

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van Hove I, Eerdekens M, Swyzen W, De Smedt G; Early Psychosis Global Working Group.

Am J Psychiatry. 2005 May;162(5):947-53.

PMID:
15863797
12.

Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis.

Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO.

Schizophr Res. 2000 Sep 29;45(1-2):1-9.

PMID:
10978867
13.

Reducing the duration of untreated first-episode psychosis: effects on clinical presentation.

Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, Simonsen E, Rund BR, Vaglum P, McGlashan T.

Arch Gen Psychiatry. 2004 Feb;61(2):143-50.

PMID:
14757590
14.
15.

Early premorbid adjustment as a moderator of the impact of duration of untreated psychosis.

Norman RM, Malla AK, Manchanda R.

Schizophr Res. 2007 Sep;95(1-3):111-4. Epub 2007 Jul 12.

PMID:
17628442
16.

Inconsistency in the relationship between duration of untreated psychosis (DUP) and negative symptoms: sorting out the problem of heterogeneity.

Schmitz N, Malla A, Norman R, Archie S, Zipursky R.

Schizophr Res. 2007 Jul;93(1-3):152-9. Epub 2007 May 3.

PMID:
17481857
17.

One year outcome in first episode psychosis: influence of DUP and other predictors.

Malla AK, Norman RM, Manchanda R, Ahmed MR, Scholten D, Harricharan R, Cortese L, Takhar J.

Schizophr Res. 2002 Apr 1;54(3):231-42.

PMID:
11950548
18.

Symptom outcome 1 year after admission to an early psychosis program.

Addington J, Leriger E, Addington D.

Can J Psychiatry. 2003 Apr;48(3):204-7.

PMID:
12728745
19.

Olanzapine compared to quetiapine in adolescents with a first psychotic episode.

Arango C, Robles O, Parellada M, Fraguas D, Ruiz-Sancho A, Medina O, Zabala A, Bombín I, Moreno D.

Eur Child Adolesc Psychiatry. 2009 Jul;18(7):418-28. doi: 10.1007/s00787-009-0749-5. Epub 2009 Feb 5.

PMID:
19198920
20.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk